Literature DB >> 27866206

Genome-Wide STAT3 Binding Analysis after Histone Deacetylase Inhibition Reveals Novel Target Genes in Dendritic Cells.

Yaping Sun1, Matthew Iyer, Richard McEachin, Meng Zhao, Yi-Mi Wu, Xuhong Cao, Katherine Oravecz-Wilson, Cynthia Zajac, Nathan Mathewson, Shin-Rong Julia Wu, Corinne Rossi, Tomomi Toubai, Zhaohui S Qin, Arul M Chinnaiyan, Pavan Reddy.   

Abstract

STAT3 is a master transcriptional regulator that plays an important role in the induction of both immune activation and immune tolerance in dendritic cells (DCs). The transcriptional targets of STAT3 in promoting DC activation are becoming increasingly understood; however, the mechanisms underpinning its role in causing DC suppression remain largely unknown. To determine the functional gene targets of STAT3, we compared the genome-wide binding of STAT3 using ChIP sequencing coupled with gene expression microarrays to determine STAT3-dependent gene regulation in DCs after histone deacetylase (HDAC) inhibition. HDAC inhibition boosted the ability of STAT3 to bind to distinct DNA targets and regulate gene expression. Among the top 500 STAT3 binding sites, the frequency of canonical motifs was significantly higher than that of noncanonical motifs. Functional analysis revealed that after treatment with an HDAC inhibitor, the upregulated STAT3 target genes were those that were primarily the negative regulators of proinflammatory cytokines and those in the IL-10 signaling pathway. The downregulated STAT3-dependent targets were those involved in immune effector processes and antigen processing/presentation. The expression and functional relevance of these genes were validated. Specifically, functional studies confirmed that the upregulation of IL-10Ra by STAT3 contributed to the suppressive function of DCs following HDAC inhibition.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27866206      PMCID: PMC5330838          DOI: 10.1159/000450681

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  57 in total

1.  Genome-wide analysis of STAT3 binding in vivo predicts effectors of the anti-inflammatory response in macrophages.

Authors:  Andrew Paul Hutchins; Stéphane Poulain; Diego Miranda-Saavedra
Journal:  Blood       Date:  2012-02-09       Impact factor: 22.113

Review 2.  Stats: multifaceted regulators of transcription.

Authors:  Melissa M Brierley; Eleanor N Fish
Journal:  J Interferon Cytokine Res       Date:  2005-12       Impact factor: 2.607

3.  Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation.

Authors:  A M O'Farrell; D A Parry; F Zindy; M F Roussel; E Lees; K W Moore; A L Mui
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

4.  Stat3 dimerization regulated by reversible acetylation of a single lysine residue.

Authors:  Zheng-Long Yuan; Ying-Jie Guan; Devasis Chatterjee; Y Eugene Chin
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

5.  Interleukin-10-induced gene expression and suppressive function are selectively modulated by the PI3K-Akt-GSK3 pathway.

Authors:  Taras T Antoniv; Lionel B Ivashkiv
Journal:  Immunology       Date:  2011-01-24       Impact factor: 7.397

6.  Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation.

Authors:  Rui Wang; Pratima Cherukuri; Jianyuan Luo
Journal:  J Biol Chem       Date:  2005-01-13       Impact factor: 5.157

7.  Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.

Authors:  Lynn Williams; Laura Bradley; Alexandra Smith; Brian Foxwell
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

8.  The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo.

Authors:  Flavio Leoni; Gianluca Fossati; Eli C Lewis; Jae-Kwon Lee; Giulia Porro; Paolo Pagani; Daniela Modena; Maria Lusia Moras; Pietro Pozzi; Leonid L Reznikov; Britta Siegmund; Giamila Fantuzzi; Charles A Dinarello; Paolo Mascagni
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

9.  Cutting edge: Negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3.

Authors:  Yaping Sun; Y Eugene Chin; Elizabeth Weisiger; Chelsea Malter; Isao Tawara; Tomomi Toubai; Erin Gatza; Paolo Mascagni; Charles A Dinarello; Pavan Reddy
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

10.  Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway.

Authors:  Wen-hua Liu; Jing-jin Liu; Jian Wu; Lu-lu Zhang; Fang Liu; Li Yin; Mao-mao Zhang; Bo Yu
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more
  5 in total

1.  STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity.

Authors:  Evelyn C Nieves; Tomomi Toubai; Daniel C Peltier; Katherine Oravecz-Wilson; Chen Liu; Hiroya Tamaki; Yaping Sun; Pavan Reddy
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-08       Impact factor: 5.742

2.  PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease.

Authors:  Katiri J Snyder; Nina C Zitzer; Yandi Gao; Hannah K Choe; Natalie E Sell; Lotus Neidemire-Colley; Anora Ignaci; Charuta Kale; Raymond D Devine; Maria G Abad; Maciej Pietrzak; Min Wang; Hong Lin; Yang W Zhang; Gregory K Behbehani; Jane E Jackman; Ramiro Garzon; Kris Vaddi; Robert A Baiocchi; Parvathi Ranganathan
Journal:  JCI Insight       Date:  2020-04-23

Review 3.  HDAC Inhibitors in Acute Myeloid Leukemia.

Authors:  Edurne San José-Enériz; Naroa Gimenez-Camino; Xabier Agirre; Felipe Prosper
Journal:  Cancers (Basel)       Date:  2019-11-14       Impact factor: 6.639

4.  JAK-STAT Pathway Inhibition Partially Restores Intestinal Homeostasis in Hdac1- and Hdac2-Intestinal Epithelial Cell-Deficient Mice.

Authors:  Alexis Gonneaud; Naomie Turgeon; Francois-Michel Boisvert; Francois Boudreau; Claude Asselin
Journal:  Cells       Date:  2021-01-23       Impact factor: 6.600

Review 5.  Biology and therapeutic potential of interleukin-10.

Authors:  Margarida Saraiva; Paulo Vieira; Anne O'Garra
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.